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ABSTRACT
Objective: To objective of this work was to perform phytochemical qualitative and quantitative analyzes of the main secondary metabolites in the 
root of Berberis microphylla.
Methods: The extracts of B. microphylla root were tested through phytochemical screening and the quantification of the most important constituents 
was carried out using spectrophotometric and gravimetric techniques.
Results: Phytochemical screening of both extracts showed the presence of alkaloids, flavonoids, glycosides, cardiac glycosides, saponins, terpenes, 
and tannins, which are pharmacologically important. Quantification of the major phytochemicals groups showed that the ethanolic extract contains 
3.9% alkaloids, 0.46% flavonoids, 9.53% tannins, and 3.60% saponins. Similarly, the methanolic extract contains 6.61% alkaloids, 0.41% flavonoids, 
7.40% tannins, and 1.43% saponins.
Conclusion: This is the first time that the presence of tannins, flavonoids, and saponins in this plant has been reported. The medicinal properties of 
the root of B. microphylla may exist due to the presence secondary metabolites.
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INTRODUCTION
There are about 500 species of Berberis worldwide, located mainly 
in Eurasia with approximately 300 species and 200 species in South 
America [1]. In Southern Chile and Argentina, from the 60 species 
previously reported in 1961 [2], currently, 20 species are recognized [3]. 
This important reduction is explained by several species, such Berberis 
heterophylla and Berberis buxifolia, being grouped into one species, 
Berberis microphylla [4]. Berberis species are deciduous or evergreen 
shrubs with a height of up to 5 meters tall and thorny stems, which are 
native to temperate and subtropical regions of Europe, Africa, North and 
South America [5]. At present, a large number of species of Berberis have 
been reported with pharmacological and clinical use [6]. In homeopathy 
and ethnic medicine, these species have been used as medicine for 
their anti-inflammatory [7], antibacterial, antihypertensive, anticancer, 
antiarrhythmic [8], hypoglycemic [8,9], and hepatoprotective [10-12] 
properties. The major phytochemical studies have been conducted on 
Asian species, such as Berberis jaeschkeana, Berberis asiatica, Berberis 
aristata, and Berberis lyceum. These species showed a relatively high 
content of tannins, saponins, alkaloids, flavonoids, steroids, phenolic 
compounds, and carbohydrates [13-15].
In the Chilean-Argentina Patagonia, the Berberis genus is represented 
by 16 species of native shrubs [16], among which B. microphylla - whose 
common name is caulk - stands out as a symbol of Patagonia due to 
its widespread abundance in the region [17]. B. microphylla has also 
been medicinally used by the native peoples of Patagonia (Aónikenk, 
Selk’nam, Kawésqar) for its astringent, antipyretic, analgesic, 
antibacterial, and antiviral properties [18].
Although several articles on B. microphylla have reported the diversity 
of alkaloid compounds [19,20], there are currently no studies showing 
the presence of other secondary metabolites in this plant. For this 
reason, our research is important because it reports for the first 
time the presence of the main secondary metabolites that have been 
described with biological activity. Therefore, the objective of this work 
was to perform phytochemical qualitative and quantitative analyzes of 
the main secondary metabolites in the root of B. microphylla.
METHODS
Sample collection
Roots of B. microphylla were collected in the settlement of Bahía Mansa 
(53° 36’ 39, 38’’ S and 70° 55’ 50, 56’’ O), about 54 km South of the city 
of Punta Arenas, Chile. The plants of B. microphylla were collected, and 
taxonomic authentication was carried out by Dr. Juan Marcos Henríquez, 
botanist, and taxonomist at the Institute of Patagonia, Universidad de 
Magallanes, Chile (Voucher No: 012837).
Methanolic and ethanolic extracts preparation of B. microphylla root
We prepared extracts of the root of B. microphylla in ethanol and methanol. 
For this purpose, 100 g of root was dried, ground and extracted with 
1000 ml of alcohol (ethanol or methanol) for 72 hrs at room temperature. 
Then, the extract was filtered and concentrated in a rotary evaporator at 
40°C. Finally, the extract was lyophilized and stored at 4°C until use.
Qualitative phytochemical analysis
We carried out qualitative assays on both ethanolic and methanolic 
extracts to identify the presence of secondary metabolites, such 
as alkaloids, flavonoids, glycosides, cardiac glycosides, saponins, 
resins, phenols, tannins, triterpenes, steroids, catechins, amines, and 
anthocyanins based on a protocol previously described [21].
Quantitative phytochemical analysis
We submitted both extracts to quantitative biochemical testing to 
determine the main secondary metabolites with described medicinal 
activity, such as alkaloids [22,23], flavonoids [24], saponins [25], and 
tannins [26].
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Data analysis
Statistical analysis was completed using the R software version 3.2.2 
GNU General Public License (GNU). All analyses were performed 
in triplicate. Continuous variables are presented as mean±SD. The 
comparison between both extracts was assessed by Student’s t-test for 




Different reports highlight B. microphylla as an important source 
of alkaloid compounds [16,17]. However, there is little background 
information on other secondary metabolites of this plant. Thus, as far as 
we know, this work constitutes the first report describing the presence 
of other phytochemical constituents in the root of B. microphylla. 
Results of the qualitative phytochemical analysis are shown in Table 1. It 
is important to note that our results are consistent with those described 
for B. asiatica [15], B. aristata [14], B. tinctoria [27], and B. lyceum [28].
Quantitative analysis
We quantified four phytochemicals groups known to be important in 
natural medicine [29]. Interestingly, Tiwari et al. underlined the role 
that saponins and tannins perform in the control and management of 
hyperglycemia [30], which seems to be similar to alkaloids [28].
The total alkaloids contents were reported as mg equivalents of 
berberine. Their percentage in the methanolic extract was significantly 
higher compared to the percentage in the ethanolic extract. This may 
be due to the type of polarity of the solvent used. In the literature, there 
are various reports regarding the total alkaloid content of dry roots. For 
instance, B. thunbergii (3.47%) and B. vulgaris (2.22%) [31] show lower 
percentages than those found in B. microphylla, which may be due to the 
content of berberine, which is the main alkaloid, varying considerably 
with altitude and soil conditions for the root [31-33]. Total flavonoids 
were reported as mg equivalents of quercetin. No significant difference 
was found between the two extracts tested. In the literature, values 
of close to 2.8% of flavonoids in B. aristata are reported [34], a value 
higher than that found in B. microphylla. Total tannins contents were 
reports as mg equivalents of tannic acid. The percentage of tannins 
is roughly similar in several species of Berberis; however, the root of 
B. microphylla contained a higher percentage of tannins than those 
described for B. aristata (0.6%), B. asiatica (1.7%), B. chitria (0.73%), 
and B. lyceum (0.96%) [35]. Moreover, the percentage of saponins is 
greater in B. microphylla than in B. vulgaris (0.3%) [36]. No significant 
differences were found in both extracts tested for these phytochemical 
groups. The phytochemical composition of both extracts was expressed 
in mg g−1 of dry matter of the sample (±SD) and percentage (±SD), and 
the results are shown in Table 2.
CONCLUSION
The phytochemical study showed that the root extracts of B. microphylla 
contain important bioactive secondary metabolites, without qualitative 
differences between the ethanolic and methanolic extract of the plant. 
This would be the first time to report the presence of tannins, flavonoids, 
and saponins present in the root of B. microphylla. Quantitatively, the 
tannins would be the major group for both extracts tested. Therefore, 
their presence would support the traditional use of the plant in the 
treatment of various diseases. We are conducting further studies of the 
isolation of active components from the root of B. microphylla with cell 
lines to validate the medicinal use of this plant.
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